Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypogonadotrophic Hypogonadism”

114 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 114 results

Not applicableLooking for participantsNCT01601171
What this trial is testing

Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate

Who this might be right for
Kallmann SyndromeHypogonadotropic HypogonadismHypothalamic Amenorrhea+5 more
Centre Hospitalier Universitaire Vaudois 2,000
Not applicableStudy completedNCT05971836
What this trial is testing

The Molecular Basis of Inherited Reproductive Disorders

Who this might be right for
Hypogonadotropic HypogonadismReproductive DisorderKallmann Syndrome+1 more
Stephanie B. Seminara, MD 854
Post-approval studies (Phase 4)Ended earlyNCT05205837
What this trial is testing

A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial

Who this might be right for
HypogonadismHypogonadism, MaleHypogonadotropic Hypogonadism
Rigshospitalet, Denmark 8
Large-scale testing (Phase 3)Study completedNCT01532414
What this trial is testing

Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism

Who this might be right for
Secondary Hypogonadism
Repros Therapeutics Inc. 151
Testing effectiveness (Phase 2)Study completedNCT00911586
What this trial is testing

Pharmacokinetic Study to Determine Time to Steady-state

Who this might be right for
Male HypogonadismPrimary HypogonadismSecondary Hypogonadism
Clarus Therapeutics, Inc. 15
Not applicableUnknownNCT02871986
What this trial is testing

Pubertal Induction in Individuals With Hypogonadism

Who this might be right for
Primary AmenorrhoeaHypothalamic AmenorrhoeaHypogonadotrophic Hypogonadism+3 more
University College, London 24
Early research (Phase 1)Study completedNCT02274181
What this trial is testing

An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration

Who this might be right for
Secondary Hypogonadism
Repros Therapeutics Inc. 6
Large-scale testing (Phase 3)Study completedNCT01993212
What this trial is testing

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

Who this might be right for
Secondary Hypogonadism
Repros Therapeutics Inc. 120
Not applicableUnknownNCT00623116
What this trial is testing

Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland

Who this might be right for
Kallmann Syndrome
Hospital for Children and Adolescents, Finland 50
Not applicableStudy completedNCT00494169
What this trial is testing

Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders

Who this might be right for
Hypogonadotropic HypogonadismKallmann SyndromePuberty, Delayed+2 more
Massachusetts General Hospital 4,042
Testing effectiveness (Phase 2)Study completedNCT01386606
What this trial is testing

The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)

Who this might be right for
Secondary Hypogonadism
Repros Therapeutics Inc. 60
Not applicableUnknownNCT06094036
What this trial is testing

Physical Exercise as a Sustainability Tool in Men With Dysmetabolic Hypogonadism

Who this might be right for
Hypogonadism, MaleMetabolic SyndromeAutonomic Imbalance+2 more
Istituto Auxologico Italiano 72
Large-scale testing (Phase 3)Study completedNCT00962637
What this trial is testing

Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism

Who this might be right for
Secondary Hypogonadism
Repros Therapeutics Inc. 194
Not applicableEnded earlyNCT00529230
What this trial is testing

Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes

Who this might be right for
Advanced CancerHypogonadismPain
M.D. Anderson Cancer Center 46
Post-approval studies (Phase 4)Study completedNCT02111473
What this trial is testing

The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism

Who this might be right for
Hypogonadism
Gulhane School of Medicine 49
Post-approval studies (Phase 4)Study completedNCT01533129
What this trial is testing

The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonadotrophic Hypogonadism

Who this might be right for
Hypogonadotrophic Hypogonadism
Gulhane School of Medicine 106
Not applicableStudy completedNCT00624624
What this trial is testing

Follow-up of Serum Androgen Profile After Bariatric Surgery in Men With Obesity Related Hypogonadotropic Hypogonadism

Who this might be right for
Morbid ObesityHypogonadism
Rijnstate Hospital 24
Not applicableStudy completedNCT00392457
What this trial is testing

Investigating the Regulation of Reproductive Hormones in Adult Men

Who this might be right for
Kallmann SyndromeHypogonadismGonadal Disorder
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 175
Early research (Phase 1)Study completedNCT00493961
What this trial is testing

Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism

Who this might be right for
Kallmann SyndromeIdiopathic Hypogonadotropic HypogonadismGnRH Deficiency
Massachusetts General Hospital 27
Early research (Phase 1)Study completedNCT01438073
What this trial is testing

Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling

Who this might be right for
Hypogonadotropic HypogonadismHealthy Postmenopausal WomenAgonadism
Massachusetts General Hospital 96
Next Page